The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria;Çoklu ilaç direncinde bakteri hücre duvarι organizasyonunun ve aktif pompa sistemlerinin rolü

Mikrobiyoloji Bulteni

Volumn 41, Issue 2, 2007, Pages 309-327

  Hasdemir, Ufuk ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Active drug efflux; Multidrug resistance; Outer membrane

Indexed keywords

BACTERIAL PROTEIN; CARRIER PROTEIN;

ACTIVE TRANSPORT; CELL WALL; DRUG EFFECT; GENETICS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MULTIDRUG RESISTANCE; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT, ACTIVE; CELL WALL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MEMBRANE TRANSPORT PROTEINS;

EID: 38549102800     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Nikaido H. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol 2001; 12: 215-23.
2. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Bio Rev 2003; 67: 593-656.
3. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs 2004; 64: 159-204.
4. Grkovic S, Brown MH, Skurray RA. Regulation of bacterial drug efflux systems. Microbiol Mol Bio Rew 2002; 66: 671-701.
5. Nikaido H. The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access? Drug Resistance Updates 1998; 1: 93-8.
6. Jeanteur D, Lakey JH, Pattus F. The bacterial porin super-family: sequence alignment and structure prediction. Mol Microbiol 1994; 5: 2153-64.
7. Nikaido H, Rosenberg EY, Foulds J. Porin channels in Escherichia coli: studies with β-lactams in intact cells. J Bacteriol 1983; 153: 232-40.
8. Rosenberg E, Bertenthal D, Nilles ML, Bertrand KP, Nikaido H. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol Microbiol 2003; 48: 1609-19.
9. Rosner JL, Chai KJ, Foulds J. Regulation of OmpF porin expression by salicylate in Escherichia coli. J Bacteriol 1991; 173: 5631-8.
10. Yoshimura F, Nikaido H. Diffusion of β-lactam antibiotics through porin channels of Escherichia coli K-12. Antimicrob Agents Chemother 1985; 27: 84-92.
11. Charrel RN, Pagès J-M, de Micco P, Malléa M. Prevalence of outer membrane porin alteration in β-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob Agents Chemother 1996; 40: 2854-8.
12. Hasdemir UO, Chevalier J, Nordmann P, Pagès JM. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol 2004; 42: 2701-06.
13. Nikaido H, Nikaido K, Harayama S. Identification and charaterization of porins in Pseudomonas aeruginosa. J Biol Chem 1991; 266: 770-9.
14. Quinne JP, Dudek EJ, Divincenzo CA, Lucks DA, Lerner SA. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J Infect Dis 1986; 154: 289-94.
15. Poole K. Efflux mediated resistance in gram-negative bacteria. Clin Microbiol Infect 2004; 10: 12-24.
16. Poole K. Efflux mediated resistance to flouroquinolones in gram positive bacteria and mycobacteria. Antimicrob Agents Chemother 2000; 44: 2595-9.
17. Pradel E, Pagès JM. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob Agents Chemother 2002; 46: 2640-3.
18. Poole K. Efflux mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 2000; 44: 2233-41.
19. Mazzariol A, Tokue Y, Kanegawa TM, Cornaglia G, Nikaido H. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother 2000; 44: 3441-3.
20. Schneiders T, Amyes SGB, Levy SB. Role of AcrR and RamA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother 2003; 47: 2831-7.
21. Kobayashi N, Nishino K, Yamaguchi A. Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J Bacteriol 2001; 183: 5639-44.
22. Ziha-Zarifi I, Llanes C, Köhler T, et al. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeniginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob Agents Chemother 1999; 43: 287-91.
23. Ochs MM, McCusker MP, Bains M, et al. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob Agents Chemother 1999; 43: 1085-90.
24. Tennent JM, Lyon BR, Midgley M, et al. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J Gen Microbiol 1989; 135 (pt 1): 1-10.
25. Kaatz GW, McAleese F, Seo SM. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob Agents Chemother 2005; 49: 1857-64.
26. Tait-Kamradt A, Clancy J, Cronan M, et al. mefE is necessary for the erythromycin-resistance M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother 1997; 41: 2251-5.
27. Jonas BM, Murray BE, Weinstock GM. Characterization of emeA, a norA homolog and multidrug resistance efflux pump in Enterococcus faecalis. Antimicrob Agents Chemother 2001; 45: 3574-9.
28. Jarlier V, Nikaido H. Permeability barrier to hydrophilic solutes in Mycobacterium chelonae. J Bacteriol 1990; 172: 1418-23.
29. Takiff HE, Cimino M, Musso MC, et al. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci U S A 1996; 93: 362-6.
30. Silva PE, Bigi F, de la Paz santagelo M, et al. Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob Agents Chemother 2001; 45: 800-4.
31. Viveiros M, Portugal I, Bettencourt R, et al. Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2002; 46: 2804-10.
32. Lomovskaya O, Warren MS, Lee A, et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105-16.
33. Stermitz FR, Lorenz P, Tawara JN. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci U S A 2000; 97: 1433-7.